On this page
# IPO-Bound Companies: Top Unlisted Shares to Watch in 2025–2026
India's IPO market is running at its hottest pace in years. SEBI received a record number of DRHP filings in 2024, and the queue for 2025–2026 is even longer. For investors in unlisted shares, the IPO pipeline is the single most important macro event to track — a listing crystallises the value of what was previously an illiquid position.
This article explains how to read the IPO pipeline, what signals matter, and which categories of unlisted companies are most likely to reach the markets in the next 12–24 months.
Disclaimer: This article is educational and not investment advice. Past IPO performance is no guarantee of future returns. Investing in unlisted shares carries significant risk, including the possibility of total loss. Consult a SEBI-registered investment adviser before making any decision.
How India's IPO Cycle Works
A company's journey from private to public follows a predictable path:
- 1DRHP filing — The company files a Draft Red Herring Prospectus with SEBI. This is public, searchable, and is the clearest signal that a listing is planned. SEBI has up to 75 days to issue observations.
- 2SEBI observation letter — SEBI may ask for clarifications or changes. Once addressed, the company has 12 months to open the IPO.
- 3RHP filing — The final Red Herring Prospectus is filed, the price band is set, and the IPO opens within weeks.
- 4Listing — Shares begin trading on BSE/NSE. Pre-IPO shareholders face a 1-year lock-in under SEBI's revised rules.
The gap between DRHP filing and actual listing is typically 6–18 months. This is the window where unlisted share prices tend to move most sharply.
What Drives the 2025–2026 IPO Boom
Several structural factors are converging:
- Retail investor participation is at an all-time high — demat accounts crossed 170 million in 2024, creating a deep retail bid for new listings.
- Domestic mutual funds have raised record equity AUM, giving institutional anchor investors ample dry powder to support large IPOs.
- PE/VC exit pressure — Several funds that backed India's 2017–2021 startup wave are now in their exit window. IPO remains the preferred route over a secondary sale or strategic acquisition.
- SEBI's faster process — SEBI has streamlined the confidential DRHP route, allowing companies to test investor appetite before a public filing.
Categories of Companies Likely to List
### 1. New-Economy Consumer Brands
India's new-economy consumer companies — quick commerce, food delivery, fashion e-commerce — are maturing to a point where profitability is no longer a distant promise. Companies in this space that filed DRHPs or signalled IPO intent in 2023–2024 are working through the pipeline in 2025.
What to watch: Quarterly EBITDA trend (turning positive), gross merchandise value growth, and customer retention rates. Investors pricing these businesses on a revenue multiple should track GMV/revenue ratio as profitability scales.
### 2. Exchange Infrastructure Plays
India's financial market infrastructure is undergoing a once-in-a-generation upgrade. Depositories, clearing corporations, and exchange ancillaries that were previously inaccessible to retail investors have been steadily appearing on the secondary market.
What to watch: Regulatory ownership caps (SEBI limits any single entity's holding in depositories), which creates a natural float when large promoters divest. The ISIN is your friend — search SEBI's DRHP database before buying any exchange-infrastructure unlisted share.
### 3. Fintech Platforms That Have Achieved Profitability
The era of loss-funding for growth is over. Fintech companies that reached operating profitability in 2023–2024 are the most credible IPO candidates. Investors pricing fintech unlisted shares should focus on net revenue margin (after payment gateway costs and credit losses) rather than gross transaction volume.
What to watch: RBI licence status (payment aggregator, NBFC-AA, or co-lending) as regulatory compliance is table-stakes for SEBI approval.
### 4. Healthcare and Diagnostics
Healthcare is a structurally defensive sector that tends to list well in volatile markets. Several diagnostic chains, hospital networks, and medical device companies that expanded post-COVID are now at the size and cash-flow stability that makes a listing viable.
What to watch: Bed occupancy rates (hospitals), collection realisation (diagnostics), and EBITDA margin trend over the last eight quarters.
How to Read IPO Signals in the Unlisted Market
### DRHP as a Price Catalyst When a company files a DRHP, unlisted share prices often jump 20–40% within days. This is the market pricing in the certainty of a listing. If you're already holding, this is a good moment to assess whether your return expectation is met. If you're looking to enter, the spike may already reflect the news.
### Funding Rounds as a Benchmark The last closed funding round — whether Series D, Series E, or a pre-IPO round — provides the most reliable benchmark for unlisted share prices. If the secondary market price is trading at a 30–40% discount to the last round valuation, that gap is worth investigating. If it's at a premium, understand why: improved financials, IPO hype, or thin supply.
### The 'Banker Appointment' Signal When a company quietly appoints investment bankers (typically announced in regulatory filings or financial media), it is almost always in pre-DRHP preparation. This can be 6–9 months ahead of the actual filing and represents the earliest actionable signal.
Risks Specific to Pre-IPO Investing
- IPO delay or cancellation — SEBI can reject a DRHP, market conditions can deteriorate, or promoters may defer. A 2-year delay is not unusual.
- Price at listing below buy price — Many unlisted share prices run ahead of fundamentals on IPO hype. If the public issue is priced below your cost, you incur a loss even on a "successful" listing.
- Lock-in period — Pre-IPO investors typically face a 1-year lock-in after listing under SEBI's current rules. You cannot sell on listing day.
- Liquidity before IPO — If you need to exit before the IPO, you depend on finding another buyer in the unlisted market. Platforms like Polemarch facilitate this, but the market is thinner than a stock exchange.
How Polemarch Fits In
Every unlisted share on Polemarch settles directly to the buyer's demat account (CDSL or NSDL) via a verified off-market transfer. When the company lists, your shares automatically convert to listed status — no intervention needed.
Polemarch shows the current transaction price, the last-round valuation benchmark, and a liquidity indicator for each company. These are tools to help you research, not recommendations to buy or sell.
*This article is published by the Polemarch editorial team for educational purposes. It does not constitute investment advice or a solicitation to buy or sell any security. Past performance of listed companies is not indicative of future results for the unlisted names mentioned. Please read all risk disclosures before investing.*